High indoleamine 2,3-dioxygenase 1 (IDO1) levels are also correlated with a decreased GBM patient survival, and it was shown that Tregs facilitate IDO1 immunosuppression, leading to decreased activities of CD8+ effector T cells and overall T cell immune response (144). This evidence concerns the gene CD8A and glioblastoma.